Overexpression of aldehyde dehydrogenase 1A1 reduces oxidation-induced toxicity in SH-SY5Y neuroblastoma cells

Journal of Neuroscience Research

Volumn 88, Issue 3, 2010, Pages 686-694

  Zhang, M ^a   Shoeb, M ^a   Goswamy, J ^b   Liu, P ^a   Xiao, T L ^a   Hogan, D ^a   Campbell, G A ^a   Ansari, Naseem H ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

4 Hydroxynonenal; Apoptosis; Lipid peroxidation; Neurodegeneration; Oxidative stress

Indexed keywords

4 HYDROXYNONENAL; ALDEHYDE DEHYDROGENASE; CASPASE 3;

ARTICLE; CELL LINE; CYTOTOXICITY; DEGENERATIVE DISEASE; DETOXIFICATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROPROTECTION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALDEHYDE DEHYDROGENASE; ALDEHYDES; BLOTTING, WESTERN; CASPASE 3; CELL LINE; CELL LINE, TUMOR; GENETIC VECTORS; HUMANS; HYDROGEN PEROXIDE; IMMUNOHISTOCHEMISTRY; ISOENZYMES; NEURONS; OXIDATIVE STRESS; TRANSFECTION;

EID: 73949097562     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22230     Document Type: Article

References (57)

1. Ando Y, Brannstrom T, Uchida K, Nyhlin N, Nasman B, Suhr O, Yamashita T, Olsson T, El Salhy M, Uchino M, Ando M. 1998. Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid. J Neurol Sci 156:172-176.
2. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NME, Romano DM, Hartshorn MA, Tanzi RE, Bush AI. 1998. Dramatic aggregation of Alzheimer Ab by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 273:12817-12826.
3. Bhor VM, Sivakami S. 2003. Regional variations in intestinal brush border membrane fluidity and function during diabetes and the role of oxidative stress and non-enzymatic glycation. Mol Cell Biochem 252:125-132.
4. Butterfield DA, Hensley K, Harris M, Mattson M, Carney J. 1994. b-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem Biophys Res Commun 200:710-715.
5. Butterfield DA, Reed T, Perluigi M, De Marco C, Coccia R, Cini C, Sultana R. 2006. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neurosci Lett 397:170-173.
6. Camandola S, Poli G, Mattson MP. 2000. The lipid peroxidation product 4-hydroxy-2,3-nonenal increases AP-1-binding activity through caspase activation in neurons. J Neurochem 74:159-168.
7. Castellani RJ, Perry G, Siedlak SL, Nunomura A, Shimohama S, Zhang J, Montine T, Sayre LM, Smith MA. 2002. Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans. Neurosci Lett 319:25-28.
8. Chen JJ, Yu BP. 1994. Alterations in mitochondrial membrane fluidity by lipid peroxidation products. Free Radic Biol Med 17:411-418.
9. Chen K, Maley J, Yu PH. 2006. Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis. J Neurochem 99:1413-1424.
10. Choudhary S, Zhang W, Zhou F, Campbell GA, Chan LL, Thompson EB, Ansari NH. 2002. Cellular lipid peroxidation end-products induce apoptosis in human lens epithelial cells. Free Radic Biol Med 32:360-369.
11. Choudhary S, Xiao T, Vergara LA, Srivastava S, Nees D, Piatigorsky J, Ansari NH. 2005. Role of aldehyde dehydrogenase isozymes in the defense of rat lens and human lens epithelial cells against oxidative stress. Invest Ophthalmol Vis Sci 46:259-267.
12. Dalfó E, Portero-Otín M, Ayala V, Martinez A, Pamplona R, Ferrer I. 2005. Evidence of oxidative stress in the neocortex in incidental Lewy body disease. J Neuropathol Exp Neurol 64:816-830.
13. Esterbauer H, Schaur RJ, Zollner H. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81-128.
14. Galter D, Buervenich S, Carmine A, Anvret M, Olson L. 2003. ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia. Neurobiol Dis 14:637-647.
15. Halliwell B. 1992. Reactive oxygen species and the central nervous system. J Neurochem 59:1609-1623.
16. Haynes RL, Szweda L, Pickin K, Welker ME, Townsend AJ. 2000. Structure-activity relationships for growth inhibition and induction of apoptosis by 4-hydroxy-2-nonenal in Raw 264.7 cells. Mol Pharmacol 58:788-794.
17. Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, Floyd RA, Butterfield DA. 1994. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease. Proc Natl Acad Sci U S A 91:3270-3274.
18. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251.
19. Honda K, Casadesus G, Petersen RB, Perry G, Smith MA. 2004. Oxidative stress and redox-active iron in Alzheimer's disease. Ann N Y Acad Sci (Redox-Active Metals in Neurological Disorders) 1012:179-182.
20. Ji C, Amarnath V, Pietenpol JA, Marnett LJ. 2001. 4-Hydroxynonenal induces apoptosis via caspase-3 activation and cytochrome c release. Chem Res Toxicol 14:1090-1096.
21. Kamino K, Nagasaka K, Imagawa M, Yamamoto H, Yoneda H, Ueki A, Kitamura S, Namekata K, Miki T, Ohta S. 2000. Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population. Biochem Biophys Res Commun 273:192-196.
22. Keller JN, Pang Z, Geddes JW, Begley JG, Germeyer A, Waeg G. 1997. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloidβ-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem 69:273-284.
23. Kerr JFR. 2002. History of the events leading to the formulation of the apoptosis concept. Toxicology 181-182:471-474.
24. Kerr JF, Wyllie AH, Currie AR. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257.
25. Kruman I, Bruce-Keller AJ, Bredesen D, Waeg G, Mattson MP. 1997. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci 17:5089-5100.
26. Lauderback CM, Hackett JM, Keller JN, Varadarajan S, Szweda L, Kindy M, Markesbery WR, Butterfield DA. 2001. Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): implications for Alzheimer's disease. Biochemistry 40:2548-2554.
27. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH. 2006. A specific amyloid-b protein assembly in the brain impairs memory. Nature 440:352-357.
28. Li Y-J, Scott WK, Zhang L, Lin P-I, Oliveira SA, Skelly T, Doraiswamy MP, Welsh-Bohmer KA, Martin ER, Haines JL, Pericak-Vance MA, Vance JM. 2006. Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases. Neurobiol Aging 27:1087-1093.
29. Lovell MA, Xie C, Markesbery WR. 1998. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology 51:1562-1566.
30. Majno G, Joris I. 1995. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146:3-15.
31. Mark RJ, Lovell MA, Markesbery WR, Uchida K. 1997. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J Neurochem 68:255-264.
32. Markesbery WR, Lovell MA. 1998. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 19:33-36.
33. Mattson MP, Duan W. 1999. "Apoptotic" biochemical cascades in synaptic compartments: roles in adaptive plasticity and neurodegenerative disorders. J Neurosci Res 58:152-166.
34. Montine KS, Olson SJ, Amarnath V, Whetsell WO Jr, Graham DG, Montine TJ. 1997. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. Am J Pathol 150:437-443.
35. Ohta S, Ohsawa I. 2006. Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: on defects in the cytochrome c oxidase complex and aldehyde detoxification. J Alzheimers Dis 9:155-166.
36. Pedersen WA, Fu W, Keller JN, Markesbery WR, Appel S, Smith RG, Kasarskis E, Mattson MP. 1998. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol 44:819-824.
37. Pinhel MA, Nakazone MA, Cacao JC, Piteri RC, Dantas RT, Godoy MF, Godoy MR, Tognola WA, Conforti-Froes ND, Souza D. 2008. Glutathione S-transferase variants increase susceptibility for late-onset Alzheimer's disease: association study and relationship with apolipoprotein E e4 allele. Clin Chem Lab Med 46:439-445.
38. Praticò D. 2002. Oxidative imbalance and lipid peroxidation in Alzheimer's disease. Drug Dev Res 56:446-451.
39. Rabacchi SA, Friedman WJ, Shelanski ML, Troy CM. 2004. Divergence of the apoptotic pathways induced by 4-hydroxynonenal and amyloid β-protein. Neurobiol Aging 25:1057-1066.
40. Ribe EM, Serrano-Saiz E, Akpan N, Troy CM. 2008. Mechanisms of neuronal death in disease: defining the models and the players. Biochem J 415:165-182.
41. Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA. 1997. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 68:2092-2097.
42. Sayre LM, Perry G, Smith MA. 2008. Oxidative stress and neurotoxicity. Chem Res Toxicol 21:172-188.
43. Shi Q, Gibson GE. 2007. Oxidative stress and transcriptional regulation in Alzheimer disease. Alzheimer Dis Assoc Disord 21:276-291.
44. Siegel SJ, Bieschke J, Powers ET, Kelly JW. 2007. The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation. Biochemistry 46:1503-1510.
45. Silvestri C, Narimatsu M, von Both I, Liu Y, Tan NBJ, Izzi L, McCaffery P, Wrana JL, Attisano L. 2008. Genome-wide identification of Smad/Foxh1 targets reveals a role for Foxh1 in retinoic acid regulation and forebrain development. Dev Cell 14:411-423.
46. Smith RG, Henry YK, Mattson MP, Appel SH. 1998. Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Ann Neurol 44:696-699.
47. Spalletta G, Bernardini S, Bellincampi L, Federici G, Trequattrini A, Ciappi F, Bria P, Caltagirone C, Bossu P. 2007. Glutathione S-transferase P1 and T1 gene polymorphisms predict longitudinal course and age at onset of Alzheimer disease. Am J Geriatr Psychiatry 15:879-887.
48. Subramaniam R, Roediger F, Jordan B, Mattson MP, Keller JN, Waeg G, Butterfield DA. 1997. The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins. J Neurochem 69:1161-1169.
49. Tamagno E, Robino G, Obbili A, Bardini P, Aragno M, Parola M, Danni O. 2003. H2O2 and 4-hydroxynonenal mediate amyloid β-induced neuronal apoptosis by activating jnks and p38mapk. Exp Neurol 180:144-155.
50. Tchaikovskaya T, Fraifeld V, Urphanishvili T, Andorfer JH, Davies P, Listowsky I. 2005. Glutathione S-transferase hGSTM3 and ageing-associated neurodegeneration: relationship to Alzheimer's disease. Mech Ageing Dev 126:309-315.
51. Uchida K. 2003. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 42:318-343.
52. Xiao T, Choudhary S, Zhang W, Ansari NH, Salahudeen A. 2003. Possible involvement of oxidative stress in cisplatin-induced apoptosis in LLC-PK1 cells. J Toxicol Environ Health A 66:469-479.
53. Xiao T, Choudhary S, Vergara LA, Van Kuijk FJGM, Ansari NH. 2004. Oxidative stress induced formation of 4-hydroxynonenal-protein adducts in lens epithelium: implication in oxidative cataractogenesis. J Tissue Res 4:181-188.
54. Xiao TL, Shoeb M, Siddiqui MS, Zhang M, Ramana KV, Srivastava S, Vasiliou V, Ansari NH. 2009. Molecular cloning and oxidative modification of human lens ALDH1A1: implication in impaired detoxification of lipid aldehydes. J Toxicol Environ Health 72:577-584.
55. Xie C, Lovell MA, Xiong S, Kindy MS, Guo J-T, Xie J, Amaranth V, Montine TJ, Markesbery WR. 2001. Expression of glutathione-S-transferase isozyme in the SY5Y neuroblastoma cell line increases resistance to oxidative stress. Free Radic Biol Med 31:73-81.
56. Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y. 1996. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci U S A 93:2696-2701.
57. Zhang W, He Q, Chan LL, Zhou F, El Naghy M, Thompson EB, Ansari NH. 2001. Involvement of caspases in 4-hydroxy-alkenalinduced apoptosis in human leukemic cells. Free Radic Biol Med 30:699-706.